Utilize este identificador para referenciar este registo:
https://hdl.handle.net/10216/118187Registo completo
| Campo DC | Valor | Idioma |
|---|---|---|
| dc.creator | Pérez-Cabezas, B | - |
| dc.creator | Cecílio, P | - |
| dc.creator | Robalo, AL | - |
| dc.creator | Silvestre, R | - |
| dc.creator | Carrillo, E | - |
| dc.creator | Moreno, J | - |
| dc.creator | San, Martín J | - |
| dc.creator | Vasconcellos, R | - |
| dc.creator | Cordeiro-da-Silva, A | - |
| dc.date.accessioned | 2019-01-08T09:55:02Z | - |
| dc.date.available | 2019-01-08T09:55:02Z | - |
| dc.date.issued | 2016 | - |
| dc.identifier.issn | 1664-3224 | - |
| dc.identifier.uri | https://repositorio-aberto.up.pt/handle/10216/118187 | - |
| dc.description.abstract | The complexity of Leishmania-host interactions, one of the main leishmaniasis issues, is yet to be fully understood. We detected elevated IL-27 plasma levels in European patients with active visceral disease caused by Leishmania infantum, which returned to basal levels after successful treatment, suggesting this cytokine as a probable infection mediator. We further addressed this hypothesis recurring to two classical susceptible visceral leishmaniasis mouse models. BALB/c, but not C57BL/6 mice, showed increased IL-27 systemic levels after infection, which was associated with an upregulation of IL-27p28 expression by dendritic cells and higher parasite burdens. Neutralization of IL-27 in acutely infected BALB/c led to decreased parasite burdens and a transient increase in IFN-¿ + splenic T cells, while administration of IL-27 to C57BL/6 promoted a local anti-inflammatory cytokine response at the site of infection and increased parasite loads. Overall, we show that, as in humans, BALB/c IL-27 systemic levels are infection dependently upregulated and may favor parasite installation by controlling inflammation. | - |
| dc.description.sponsorship | This work was supported by Fundação para a Ciência e Tecnologia (FCT)/Ministério da Educação e da Ciência (MEC), co-funded by FEDER under the PT2020 Partnership Agreement through the Research Unit NO. 4293; by European Community’s Seventh Framework Programme under grant agreement No. 603182 (Project MuLeVaClin) and by the ISCIII-AES project (project reference PI13/00440). PC and BP-C are supported by fellowships from the European Community’s Seventh Framework Programme under grant agreements No. 603182 (Project MuLeVaClin) and No. 603240-2 (Project NMTryPI), respectively. | - |
| dc.language.iso | eng | - |
| dc.publisher | Frontiers Media | - |
| dc.relation.ispartof | Frontiers in Immunology, vol.7: 478 | - |
| dc.rights | openAccess | - |
| dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | - |
| dc.subject | IL-27 | - |
| dc.subject | Leishmania Infantum | - |
| dc.subject | Human | - |
| dc.subject | Immune Regulation | - |
| dc.subject | Mouse Models | - |
| dc.title | Interleukin-27 early impacts Leishmania infantum infection in mice and correlates with active visceral disease in humans | - |
| dc.type | Artigo em Revista Científica Internacional | - |
| dc.contributor.uporto | Instituto de Investigação e Inovação em Saúde | - |
| dc.identifier.doi | 10.3389/fimmu.2016.00478 | - |
| dc.relation.publisherversion | https://www.frontiersin.org/articles/10.3389/fimmu.2016.00478/full | - |
| Aparece nas coleções: | I3S - Artigo em Revista Científica Internacional | |
Ficheiros deste registo:
| Ficheiro | Descrição | Tamanho | Formato | |
|---|---|---|---|---|
| Begona_IL27_Front Immunol_2016.pdf | 3.98 MB | Adobe PDF | ![]() Ver/Abrir |
Este registo está protegido por Licença Creative Commons
